| dc.contributor.author | Sandamali, J.A.N. | |
| dc.contributor.author | Hewawasam, R.P. | |
| dc.contributor.author | Jayatilaka, K.A.P.W. | |
| dc.date.accessioned | 2022-09-13T08:58:44Z | |
| dc.date.available | 2022-09-13T08:58:44Z | |
| dc.date.issued | 2018-11-08 | |
| dc.identifier.citation | Sandamali, J. A. N. , Hewawasam, R. P. , & Jayatilaka, K. A. P. W. (2018). Effect of Murraya koenigii Leaf Extract on Antioxidant Status, Lipid Peroxidation and Myeloperoxidase Activity in Wistar Rats Treated with Doxorubicin. 1 st Research Symposium of Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka, 10. | en_US |
| dc.identifier.issn | 2659-2029 | |
| dc.identifier.uri | http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/8304 | |
| dc.description.abstract | Background: Doxorubicin is one of the most potent and widely used chemotherapeutic agents. However, clinical utility is limited by dose-dependent cardiotoxicity, which leads to severe heart failure. Previous studies favour reactive oxygen species as one of the main factors responsible for doxorubicin-induced cardiotoxicity and administration of antioxidants has been shown to protect cardiac tissues. Murraya koenigii leaves are rich in various phytochemicals and have strong antioxidant potential. Objectives: To investigate the effect of aqueous extract of Murraya leaf on antioxidant status, lipid peroxidation and myeloperoxidase activity in Wistar rats treated with doxorubicin. Methodology: Wistar rats were divided into five groups of 10 animals in each. Group 1 served as the normal control. Group 2, plant extract control received 2.0 g/kg lyophilized plant extract for 14 days and 10 mL/kg saline on 11th day. Group 3 received 2.0 g/kg lyophilized plant extract for 14 days and 18 mg/kg doxorubicin on 11th day while group 4 received 10 mL/kg distilled water for 14 days, 18 mg/kg doxorubicin on 11th day. Group 5 which served as the positive control was given 10 mL/kg dH2O for 14 days, 180 mg/kg dexrazoxane 0.5 hr prior to administration of doxorubicin (18 mg/kg). Animals were sacrificed on the 15th day. A portion of heart tissues was collected for the estimation of antioxidant parameters. Results and conclusions: A significant reduction in reduced glutathione, glutathione reductase, glutathione peroxidase, total antioxidant capacity, superoxide dismutase and catalase activity and a significant increase in lipid peroxidation and myeloperoxidase activity was observed in doxorubicin control compared to the normal control group (p˂0.05). Plant extract treated group showed a significant decrease in lipid peroxidation, myeloperoxidase activity and significant increase in rest of the parameters compared to the doxorubicin control (p˂0.05). It can be concluded that Murraya leaf extract has the potential to ameliorate doxorubicin induced oxidative stress and inflammation in Wistar rats. | en_US |
| dc.description.sponsorship | Academic staff members of the Faculty of Allied Health Science, University of Ruhuna | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka | en_US |
| dc.subject | Doxorubicin | en_US |
| dc.subject | Murraya koenigii leaf extract | en_US |
| dc.subject | oxidative stress | en_US |
| dc.subject | Wistar rats | en_US |
| dc.title | Effect of Murraya koenigii Leaf Extract on Antioxidant Status, Lipid Peroxidation and Myeloperoxidase Activity in Wistar Rats Treated with Doxorubicin | en_US |
| dc.type | Presentation | en_US |